The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...

Global Market OverviewThe Global Non-Invasive Prenatal Testing (NIPT) Market is projected to expand at a CAGR of 16% by 2029, ...

A slippery droplet microarray enables parallel 3D bioprinting of separated, immersed hydrogel models, cutting array ...

Gene expression analysis helps uncover how cells function, adapt, and contribute to disease. Techniques from microarray preprocessing to advanced single-cell proteomics offer complementary insights ...

Cytogenetics is rapidly advancing with innovations that merge traditional chromosome analysis with automation, AI, and high-throughput genomic tools. These developments are improving speed, accuracy, ...

OGM Can Resolve Previously Unresolved Rare Disease CasesOGM Can Serve as a Gold Standard Technique for Characterization of ...

Illumina Inc (ILMN) reports robust Q1 performance with increased revenue and EPS, while raising 2026 guidance amid strong clinical market demand.

Mechanistic insights on how NRG4 suppresses obesity-driven breast cancer metastasis Breast cancer remains a leading cause of ...

For the quarter ended March 2026, Illumina (ILMN) reported revenue of $1.09 billion, up 4.8% over the same period last year. EPS came in at $1.15, compared to $0.97 in the year-ago quarter. The ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Michael is a former senior editor of investing and trading products for ...

Note: This article contains spoilers from “DTF St. Louis” Episode 7. Just like that, “DTF St. Louis” is over. The mystery has been solved, and the solution is more tragic than anyone — including ...